A Phase 1 Study to Explore the Cardiac Pharmacodynamics of MT-1303

Clinical trial NCT02193217 · COMPLETED

Trial details

NCT number: NCT02193217
Sponsor: Tanabe Pharma Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsing-remitting Multiple Sclerosis

Primary completion: 2014-12-01
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.